Absence of uterine tumours in CD-1 mice treated neonatally with subcutaneous tamoxifen or 4-hydroxyoestradiol

Experimental and Toxicologic Pathology

Volumn 59, Issue 3-4, 2007, Pages 177-185

  Razvi, Nihal ^a   Greaves, Peter ^a   Styles, Jerry ^a   Edwards, Richard ^b   White, Ian N H ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b MRC TOXICOLOGY UNIT   (United Kingdom)

Author keywords

4 Hydroxyoestradiol; Mice; Tamoxifen; Tumours; Uterus

Indexed keywords

4 HYDROXYESTRADIOL; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CONTROLLED STUDY; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM TUMOR; ESTRUS CYCLE; IMMUNOCYTOCHEMISTRY; MOUSE; NEWBORN; NONHUMAN; UTERUS TUMOR;

ANIMALIA; MUS;

EID: 35648981534     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2007.06.002     Document Type: Article

References (29)

1. Ashby J., Owens W., Odum J., and Tinwell H. The intact immature rodent uterotrophic bioassay: possible effects on assay sensitivity of vomeronasal signals from male rodents and strain differences. Environ Health Perspect 111 (2003) 1568-1570
2. Begum M., Tashiro H., Katabuchi H., Suzuki A., Kurman R.J., and Okamura H. Neonatal estrogenic exposure suppresses PTEN-related endometrial carcinogenesis in recombinant mice. Lab Invest 86 (2006) 286-296
3. Bolton J.L., Pisha E., Zhang F., and Qiu S. Role of quinoids in estrogen carcinogenesis. Chem Res Toxicol 11 (1998) 1113-1127
4. Carthew P., Edwards R.E., Nolan B.M., Martin E.A., Heydon R.T., White I.N.H., et al. Tamoxifen induces endometrial and vaginal cancer in rats in the absence of endometrial hyperplasia. Carcinogenesis 21 (2000) 793-797
5. Couse J.F., and Korach K.S. Estrogen receptor-alpha mediates the detrimental effects of neonatal diethylstilbestrol (DES) exposure in the murine reproductive tract. Toxicology 205 (2004) 55-63
6. Couse J.F., Davis V.L., Hanson R.B., Jefferson W.N., McLachlan J.A., Bullock B.C., et al. Accelerated onset of uterine tumors in transgenic mice with aberrant expression of the estrogen receptor after neonatal exposure to diethylstilbestrol. Mol Carcinog 19 (1997) 236-242
7. Cummings S.R., Eckert S., Krueger K.A., Grady D., Powles T.J., Cauley J.A., et al. The effect of raloxifene on risk of breast cancer in postmenopausal women - results from the MORE randomized trial. J Am Med Assoc 281 (1999) 2189-2197
8. Falck L., and Forsberg J.G. Immunohistochemical studies on the expression and estrogen dependency of EGF and its receptor and C-fos proto-oncogene in the uterus and vagina of normal and neonatally estrogen-treated mice. Anat Rec 245 (1996) 459-471
9. Fisher B., Costantino J.P., Redmond C.K., Fisher E.R., Wickerham D.L., and Cronin W.M. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86 (1994) 527-537
10. Fisher B., Costantino J.P., Wickerham D.L., Cecchini R.S., Cronin W.M., Robidoux A., et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97 (2005) 1652-1662
11. Fornander T., Cedermark B., Mattsson A., Skoog L., Theve T., Askergren J., et al. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1 (1989) 117-119
12. Green A.R., Styles J., Parrott E.L., Gray D.T., Edwards R.E., Smith A.G., et al. Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer. Exp Toxicol Pathol 56 4-5 (2005) 255-263
13. Gruber C.J., Tschugguel W., Schneeberger C., and Huber J.C. Production and actions of estrogens. N Engl J Med 346 (2002) 340-352
14. Hayashi N., Hasegawa K., Komine A., Tanaka Y., McLachian J.A., Barrett J.C., et al. Estrogen-induced cell transformation and DNA adduct formation in cultured Syrian hamster embryo cells. Mol Carcinog 16 (1996) 149-156
15. Li J.J., and Li S.A. Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed Proc 46 (1987) 1858-1863
16. Li S., Washburn K.A., Moore R., Uno T., Teng C., Newbold R.R., et al. Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus. Cancer Res 57 (1997) 4356-4359
17. Li S., Ma L., Chiang T., Burow M., Newbold R.R., Negishi M., et al. Promoter CpG methylation of Hox-a10 and Hox-a11 in mouse uterus not altered upon neonatal diethylstilbestrol exposure. Mol Carcinog 32 (2001) 213-219
18. Liehr J.G., Fang W.F., Sirbasku D.A., and Ari-Ulubelen A. Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem 24 (1986) 353-356
19. Maita K., Hirano M., Harada T., Mitsumori K., Yoshida A., Takahashi K., et al. Mortality, major cause of moribundity, and spontaneous tumors in CD-1 mice. Toxicol Pathol 16 (1988) 340-349
20. Nelson K.G., Sakai Y., Eitzman B., Steed T., and McLachlan J. Exposure to diethylstilbestrol during a critical developmental period of the mouse reproductive tract leads to persistent induction of two estrogen-regulated genes. Cell Growth Differ 5 (1994) 595-606
21. Newbold R.R., and Liehr J.B. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 60 (2000) 235-237
22. Newbold R.R., Bullock B.C., and McLachlan J.A. Animal-model of human-disease-diverticulosis and salpingitis isthmica nodosa (Sin) of the fallopian-tube-estrogen-induced diverticulosis and Sin of the mouse oviduct. Am J Pathol 117 (1984) 333-335
23. Newbold R.R., Bullock B.C., and McLachlan J.A. Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res 50 (1990) 7677-7681
24. Newbold R.R., Jefferson W.N., Padilla-Burgos E., and Bullock B.C. Uterine carcinoma in mice treated neonatally with tamoxifen. Carcinogenesis 18 (1997) 2293-2298
25. Newbold R.R., Banks E.P., Bullock B., and Jefferson W.N. Uterine adenocarinoma in mice treated neonatally with genistein. Cancer Res 61 (2001) 4325-4328
26. Parrott E.L., Butterworth M., Green A., White I.N.H., and Greaves P. Adenomyosis - a result of disordered stromal differentiation. Am J Pathol 159 (2001) 623-630
27. Rutqvist L.E., Johansson H., Signomklao T., Johansson U., Fornander T., and Wilking N. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst 87 (1995) 645-651
28. Van Aswegen C.H., Purdy R.H., and Wittliff J.L. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers. J Steroid Biochem 32 (1989) 485-492
29. Zheng X., and Hendry III W.J. Neonatal diethylstilbestrol treatment alters the estrogen-regulated expression of both cell proliferation and apoptosis-related proto-oncogenes (c-jun, c-fos, c-myc, bax, bcl-2, and bcl-x) in the hamster uterus. Cell Growth Differ 8 (1997) 425-434